Cancer and Metastasis Reviews

, Volume 29, Issue 3, pp 435–445 | Cite as

Cancer and metastasis: prevention and treatment by green tea



Metastasis is the most deadly aspect of cancer and results from several interconnected processes including cell proliferation, angiogenesis, cell adhesion, migration, and invasion into the surrounding tissue. The appearance of metastases in organs distant from the primary tumor is the most destructive feature of cancer. Metastasis remains the principal cause of the deaths of cancer patients despite decades of research aimed at restricting tumor growth. Therefore, inhibition of metastasis is one of the most important issues in cancer research. Several in vitro, in vivo, and epidemiological studies have reported that the consumption of green tea may decrease cancer risk. (-)-Epigallocatechin-3-gallate, major component of green tea, has been shown to inhibit tumor invasion and angiogenesis which are essential for tumor growth and metastasis. This article summarizes the effect of green tea and its major polyphenolic compounds on cancer and metastasis against most commonly diagnosed cancer sites.


Cancer EGCG Green tea Metastasis Tumor growth 



The original work from the author’s (HM) laboratory outlined in this review was supported by United States Public Health Service Grants RO1 CA 78809, RO1 CA 101039, RO1 CA 120451, and P50 DK065303.


  1. 1.
    Jemal, A., et al. (2009). Cancer statistics, 2009. CA: A Cancer Journal for Clinicians, 59(4), 225–249.CrossRefGoogle Scholar
  2. 2.
    Steeg, P. S. (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nature Medicine, 12(8), 895–904.CrossRefPubMedGoogle Scholar
  3. 3.
    Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature Reviews Cancer, 2(8), 563–572.CrossRefPubMedGoogle Scholar
  4. 4.
    Fidler, I. J., & Radinsky, R. (1996). Search for genes that suppress cancer metastasis. Journal of the National Cancer Institute, 88(23), 1700–1703.CrossRefPubMedGoogle Scholar
  5. 5.
    Gupta, G. P., & Massague, J. (2006). Cancer metastasis: building a framework. Cell, 127(4), 679–695.CrossRefPubMedGoogle Scholar
  6. 6.
    Mukhtar, H., & Ahmad, N. (2000). Tea polyphenols: prevention of cancer and optimizing health. The American Journal of Clinical Nutrition, 71(6 Suppl), 1698S–16702S.PubMedGoogle Scholar
  7. 7.
    Khan, N., Afaq, F., & Mukhtar, H. (2008). Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxidants Redox Signaling, 10(3), 475–510.CrossRefPubMedGoogle Scholar
  8. 8.
    Chacko, S. M., et al. (2010). Beneficial effects of green tea: a literature review. Chinese Medicine, 5(6), 13.CrossRefPubMedGoogle Scholar
  9. 9.
    Khan, N., & Mukhtar, H. (2007). Tea polyphenols for health promotion. Life Sciences, 81(7), 519–533.CrossRefPubMedGoogle Scholar
  10. 10.
    Cao, Y., Cao, R., & Brakenhielm, E. (2002). Antiangiogenic mechanisms of diet-derived polyphenols. The Journal of Nutritional Biochemistry, 13(7), 380–390.CrossRefPubMedGoogle Scholar
  11. 11.
    Khan, N., et al. (2006). Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Research, 66(5), 2500–2505.CrossRefPubMedGoogle Scholar
  12. 12.
    Sanchez-del-Campo, L., et al. (2009). Melanoma activation of 3-o-(3, 4, 5-trimethoxybenzoyl)-(-)-epicatechin to a potent irreversible inhibitor of dihydrofolate reductase. Molecular Pharmacology, 6(3), 883–894.CrossRefGoogle Scholar
  13. 13.
    Roomi, M. W., et al. (2006). In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline and green tea extract on human melanoma cell line A2058. In Vivo, 20(1), 25–32.PubMedGoogle Scholar
  14. 14.
    Mantena, S. K., et al. (2005). Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors. The Journal of Nutrition, 135(12), 2871–2877.PubMedGoogle Scholar
  15. 15.
    Mantena, S. K., Roy, A. M., & Katiyar, S. K. (2005). Epigallocatechin-3-gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8+ T cells in tumors. Photochemistry and Photobiology, 81(5), 1174–1179.CrossRefPubMedGoogle Scholar
  16. 16.
    Liu, J. D., et al. (2001). Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice. Journal of Cellular Biochemistry, 83(4), 631–642.CrossRefPubMedGoogle Scholar
  17. 17.
    Suzuki, Y., & Isemura, M. (2001). Inhibitory effect of epigallocatechin gallate on adhesion of murine melanoma cells to laminin. Cancer Letters, 173(1), 15–20.CrossRefPubMedGoogle Scholar
  18. 18.
    Wu, Y., et al. (2008). Inhibition of invasion and up-regulation of E-cadherin expression in human malignant melanoma cell line A375 by (-)-epigallocatechin-3-gallate. Journal of Huazhong University of Science and Technology, Medical Sciences, 28(3), 356–359.CrossRefGoogle Scholar
  19. 19.
    Evans, S., et al. (2009). The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models. Anticancer Research, 29(10), 3917–3924.PubMedGoogle Scholar
  20. 20.
    Siddiqui, I. A., et al. (2008). Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene, 27(14), 2055–2563.CrossRefPubMedGoogle Scholar
  21. 21.
    Roomi, M. W., et al. (2005). In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human prostate cancer PC-3 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry. In Vivo, 19(1), 179–183.PubMedGoogle Scholar
  22. 22.
    Saleem, M., et al. (2005). Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model. Clinical Cancer Research, 11(1), 147–153.PubMedGoogle Scholar
  23. 23.
    Adhami, V. M., et al. (2004). Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Research, 64(23), 8715–8722.CrossRefPubMedGoogle Scholar
  24. 24.
    Pezzato, E., et al. (2004). Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin-3-gallate. International Journal of Cancer, 112(5), 787–792.CrossRefGoogle Scholar
  25. 25.
    Zhou, J. R., et al. (2003). Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. The Journal of Nutrition, 133(2), 516–521.PubMedGoogle Scholar
  26. 26.
    Gupta, S., et al. (2001). Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proceedings of the National Academy of Sciences of the United States of America, 98(18), 10350–10355.CrossRefPubMedGoogle Scholar
  27. 27.
    Farabegoli, F., Papi, A., & Orlandi, M. (2010). -(-)Epigallocatechin-3-gallate downregulates EGFR, MMP-2, MMP-9 EMMPRIN and inhibits the invasion of MCF-7 tamoxifen resistant cells. Bioscience Reports. doi: 10.1042/BSR20090143.
  28. 28.
    Kushima, Y., et al. (2009). Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line. Biological & Pharmaceutical Bulletin, 32(5), 899–904.CrossRefGoogle Scholar
  29. 29.
    Sen, T., et al. (2009). Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sciences, 84(7–8), 194–204.CrossRefPubMedGoogle Scholar
  30. 30.
    Slivova, V., et al. (2005). Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells. Nutrition and Cancer, 52(1), 66–73.CrossRefPubMedGoogle Scholar
  31. 31.
    Baliga, M. S., Meleth, S., & Katiyar, S. K. (2005). Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems. Clinical Cancer Research, 11(5), 1918–1927.CrossRefPubMedGoogle Scholar
  32. 32.
    Nakachi, K., et al. (1998). Influence of drinking green tea on breast cancer malignancy among Japanese patients. Japanese Journal of Cancer Research, 89(3), 254–261.PubMedGoogle Scholar
  33. 33.
    Shimizu, K., et al. (2010). Preventive effect of green tea catechins on experimental tumor metastasis in senescence-accelerated mice. Biological & Pharmaceutical Bulletin, 33(1), 117–121.CrossRefGoogle Scholar
  34. 34.
    Roomi, M. W., et al. (2009). Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines. Oncology Reports, 22(6), 1283–1291.PubMedGoogle Scholar
  35. 35.
    Hazgui, S., et al. (2008). Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells. Respiratory Research, 9(1), 33.CrossRefPubMedGoogle Scholar
  36. 36.
    Roomi, M. W., et al. (2006). Inhibition of pulmonary metastasis of melanoma b16fo cells in C57BL/6 mice by a nutrient mixture consisting of ascorbic acid, lysine, proline, arginine, and green tea extract. Experimental Lung Research, 32(10), 517–530.CrossRefPubMedGoogle Scholar
  37. 37.
    Waheed Roomi, M., et al. (2006). In vivo and in vitro antitumor effect of a unique nutrient mixture on lung cancer cell line A-549. Experimental Lung Research, 32(9), 441–453.CrossRefPubMedGoogle Scholar
  38. 38.
    Yang, J., Wei, D., & Liu, J. (2005). Repressions of MMP-9 expression and NF-kappa B localization are involved in inhibition of lung carcinoma 95-D cell invasion by (-)-epigallocatechin-3-gallate. Biomedicine & Pharmacotherapy, 59(3), 98–103.CrossRefGoogle Scholar
  39. 39.
    Sazuka, M., et al. (1997). Inhibition of collagenases from mouse lung carcinoma cells by green tea catechins and black tea theaflavins. Bioscience, Biotechnology, and Biochemistry, 61(9), 1504–1506.CrossRefPubMedGoogle Scholar
  40. 40.
    Sazuka, M., et al. (1995). Inhibitory effects of green tea infusion on in vitro invasion and in vivo metastasis of mouse lung carcinoma cells. Cancer Letters, 98(1), 27–31.PubMedGoogle Scholar
  41. 41.
    Roomi, M. W., et al. (2008). Suppression of growth and hepatic metastasis of murine B16FO melanoma cells by a novel nutrient mixture. Oncology Reports, 20(4), 809–817.PubMedGoogle Scholar
  42. 42.
    Lee, S. J., et al. (2007). Phenolic phytochemicals derived from red pine (Pinus densiflora) inhibit the invasion and migration of SK-Hep-1 human hepatocellular carcinoma cells. Annals of the New York Academy of Sciences, 1095, 536–544.CrossRefPubMedGoogle Scholar
  43. 43.
    Wei, D. Z., et al. (2003). Inhibition of liver cancer cell proliferation and migration by a combination of (-)-epigallocatechin-3-gallate and ascorbic acid. Journal of Chemotherapy, 15(6), 591–595.PubMedGoogle Scholar
  44. 44.
    Sugiyama, T., & Sadzuka, Y. (1999). Combination of theanine with doxorubicin inhibits hepatic metastasis of M5076 ovarian sarcoma. Clinical Cancer Research, 5(2), 413–416.PubMedGoogle Scholar
  45. 45.
    Larsen, C. A., & Dashwood, R. H. (2009). Suppression of Met activation in human colon cancer cells treated with (-)-epigallocatechin-3-gallate: minor role of hydrogen peroxide. Biochemical and Biophysical Research Communications, 389(3), 527–530.CrossRefPubMedGoogle Scholar
  46. 46.
    Sukhthankar, M., et al. (2008). A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer. Gastroenterology, 134(7), 1972–1980.CrossRefPubMedGoogle Scholar
  47. 47.
    Roomi, M. W., et al. (2005). In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human colon cancer cell HCT 116 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry. Oncology Reports, 13(3), 421–425.PubMedGoogle Scholar
  48. 48.
    Kim, M., et al. (2005). (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells. Carcinogenesis, 26(9), 1553–1562.CrossRefPubMedGoogle Scholar
  49. 49.
    Shankar, S., et al. (2008). EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Frontiers in Bioscience, 13, 440–452.CrossRefPubMedGoogle Scholar
  50. 50.
    Roomi, M. W., et al. (2005). Antitumor effect of a combination of lysine, proline, arginine, ascorbic acid, and green tea extract on pancreatic cancer cell line MIA PaCa-2. International Journal of Gastrointestinal Cancer, 35(2), 97–102.CrossRefPubMedGoogle Scholar
  51. 51.
    Hiura, A., Tsutsumi, M., & Satake, K. (1997). Inhibitory effect of green tea extract on the process of pancreatic carcinogenesis induced by N-nitrosobis-(2-oxypropyl)amine (BOP) and on tumor promotion after transplantation of N-nitrosobis-(2-hydroxypropyl)amine (BHP)-induced pancreatic cancer in Syrian hamsters. Pancreas, 15(3), 272–277.CrossRefPubMedGoogle Scholar
  52. 52.
    Kato, K., et al. (2008). Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. British Journal of Cancer, 99(4), 647–654.CrossRefPubMedGoogle Scholar
  53. 53.
    Xue, H. C., et al. (2008). Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma. Ai Zheng, 27(12), 1256–1262.PubMedGoogle Scholar
  54. 54.
    Tang, F. Y., Chiang, E. P., & Shih, C. J. (2007). Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells. The Journal of Nutritional Biochemistry, 18(6), 391–399.CrossRefPubMedGoogle Scholar
  55. 55.
    Tachibana, H., et al. (2004). A receptor for green tea polyphenol EGCG. Nature Structural & Molecular Biology, 11(4), 380–381.CrossRefGoogle Scholar
  56. 56.
    Martignone, S., et al. (1993). Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. Journal of the National Cancer Institute, 85(5), 398–402.CrossRefPubMedGoogle Scholar
  57. 57.
    Menard, S., et al. (1997). New insights into the metastasis-associated 67 kD laminin receptor. Journal of Cellular Biochemistry, 67(2), 155–165.CrossRefPubMedGoogle Scholar
  58. 58.
    Singhal, S., et al. (2003). Gene expression profiling of malignant mesothelioma. Clinical Cancer Research, 9(8), 3080–3097.PubMedGoogle Scholar
  59. 59.
    Kojima-Yuasa, A., et al. (2003). Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors. Life Sciences, 73(10), 1299–1313.CrossRefPubMedGoogle Scholar
  60. 60.
    Maeda-Yamamoto, M., et al. (2003). Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells. Journal of Agricultural and Food Chemistry, 51(7), 1858–1863.CrossRefPubMedGoogle Scholar
  61. 61.
    Singh, A. K., et al. (2002). Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells. Archives of Biochemistry and Biophysics, 401(1), 29–37.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of DermatologyUniversity of WisconsinMadisonUSA

Personalised recommendations